OpenURL Connection Search

Select item for more details and to access through your institution.

Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.
Published in:
Alimentary Pharmacology & Therapeutics, 2006, v. 23, n. 4, p. 507, doi. 10.1111/j.1365-2036.2006.02785.x
By:
- FORMANN, E.;
- STEINDL‐MUNDA, P.;
- HOFER, H.;
- JESSNER, W.;
- BERGHOLZ, U.;
- GURGUTA, C.;
- FERENCI, P.
Publication type:
Article
Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE study.
Published in:
Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 28, doi. 10.1111/jvh.12614
By:
- Fevery, B.;
- Verbinnen, T.;
- Peeters, M.;
- Janssen, K.;
- Witek, J.;
- Jessner, W.;
- De Meyer, S.;
- Lenz, O.
Publication type:
Article
Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 and PROMISE studies
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 639, doi. 10.1111/jvh.12365
By:
- Scott, J.;
- Gilles, L.;
- Fu, M.;
- Brohan, E.;
- Panter, C.;
- Arbuckle, R.;
- Jessner, W.;
- Beumont, M.
Publication type:
Article
Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study ( PLUTO).
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 3, p. 468, doi. 10.1111/apt.13883
By:
- Buti, M.;
- Calleja, J. L.;
- Lens, S.;
- Diago, M.;
- Ortega, E.;
- Crespo, J.;
- Planas, R.;
- Romero‐Gómez, M.;
- Rodríguez, F. G.;
- Pascasio, J. M.;
- Fevery, B.;
- Kurland, D.;
- Corbett, C.;
- Kalmeijer, R.;
- Jessner, W.
Publication type:
Article
Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 4, p. 366, doi. 10.1111/jvh.12346
By:
- Manns, M. P.;
- Fried, M. W.;
- Zeuzem, S.;
- Jacobson, I. M.;
- Forns, X.;
- Poordad, F.;
- Peeters, M.;
- Fu, M.;
- Lenz, O.;
- Ouwerkerk‐Mahadevan, S.;
- Jessner, W.;
- Scott, J. A.;
- Kalmeijer, R.;
- De La Rosa, G.;
- Sinha, R.;
- Beumont‐Mauviel, M.
Publication type:
Article
Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection.
Published in:
Journal of Viral Hepatitis, 2007, v. 14, n. 11, p. 775, doi. 10.1111/j.1365-2893.2007.00867.x
By:
- Jessner, W.;
- Watkins-Riedel, T.;
- Müller, C.;
- Formann, E.;
- Gschwantler, M.;
- Ferenci, P.
Publication type:
Article
Twice-weekly administration of peginterferon-α -2b improves viral kinetics in patients with chronic hepatitis C genotype 1.
Published in:
Journal of Viral Hepatitis, 2003, v. 10, n. 4, p. 271, doi. 10.1046/j.1365-2893.2003.00446.x
By:
- Formann, E.;
- Jessner, W.;
- Bennett, L.;
- Ferenci, P.
Publication type:
Article
Early viral kinetics on treatment with pegylated interferon-α -2a in chronic hepatitis C virus genotype 1 infection*.
Published in:
Journal of Viral Hepatitis, 2003, v. 10, n. 1, p. 37, doi. 10.1046/j.1365-2893.2003.00396.x
By:
- Jessner, W.;
- Stauber, R.;
- Hackl, F.;
- Datz, C.;
- Watkins-Riedel, T.;
- Hofer, H.;
- Gangl, A.;
- Kessler, H.;
- Ferenci, P.
Publication type:
Article

Found: 8